Susan Schneider, PhD, RN, AOCN, FAAN, associate professor and faculty lead for the graduate oncology specialty at the Duke University School of Nursing, was elected President-elect of the Oncology Nursing Society (ONS). Schneider will assume the role of President of the 35,000 member national society for a two-year term beginning in 2016, following a year as President-elect.
“We congratulate Sue for this very well-deserved honor,” said Marion E. Broome, PhD, RN, FAAN, dean and vice chancellor for nursing affairs, Duke University and associate vice president for academic affairs for nursing, Duke University Health System. “Sue’s extensive experience in pediatric and adult oncology shapes not only how she educates her students, but also guides her research. I am confident that her experience and strong leadership skills will enable her to lead members of this vibrant organization to continue thrive and meet the challenges of the next decade.” Broome said.
Schneider will be inducted as President-elect at the ONS Annual Congress in late April. She will serve on the Board of Directors of the Society for a total of three years—the first year as President-elect and two years as President.
“It’s an honor and a privilege to have been selected to serve an organization that I feel so passionately about and am committed to,” said Schneider. “I look forward to continuing the education, research and outreach efforts that are currently underway with the Society and giving back to an organization that has given so much to me.”
Prior to joining the faculty at Duke University, Schneider taught in the oncology program at Frances Payne Bolton School of Nursing at Case Western Reserve University and was a clinical nurse specialist at University Hospitals of Cleveland. She is professionally active in a number of nursing organizations. She has chaired the American Cancer Society Peer Review Committee on Scholarships and Professorships in Oncology Nursing and served as a member of the ONS National Board of Directors. Schneider has received both the Excellence in Cancer Nursing Research and Excellence in Cancer Nursing Education awards from ONS and is a Fellow of the American Academy of Nursing.
Her research interests include management of symptom distress in cancer patients, the use of distraction interventions to enhance coping and the use of tailored protocols to promote chemotherapy adherence.
The beginning of the ONS can be traced to the first National Cancer Nursing Research Conference, supported by the American Nurses Association and the American Cancer Society in 1973. Following this conference, a small group of oncology nurses met to discuss the need for a national organization to support their profession. It was officially incorporated in 1975. Today, it has grown to include more than 225 local chapters and advocates for oncology nurses at the national level.